COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 664: Articles 6631-6640  | Next

Vaccine effectiveness for preventing COVID-19 hospital admission during pregnancy: a population-based cohort study in England during the Alpha and Delta waves of the SARS-CoV-2 pandemic
Bosworth, M. L., Schofield, R., Ayoubkhani, D., Charlton, L., Nafilyan, V., Khunti, K., Zaccardi, F., Gillies, C., Akbari, A., Knight, M., Wood, R., Hardelid, P., Zuccolo, L., Harrison, C.
10.1101/2022.09.27.22280397 — Posted: 2022-09-27
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease
Schutzer Godoy, A., Minalli Nakamura, A., Douangamath, A., Song, Y., Dias Noske, G., Oliveira Gawriljuk, V., Sachetto Fernandes, R., D. Muniz Pereira, H., Irene Zagato Oliveira, K., Fearon, D., Dias, A., Krojer, T., Fairhead, M., Powell, A., Dunnet, L., Brandao-Neto, J., Skyner, R., Chalk, R., von Delft, F., Bajusz, D., Bege, M., Borbas, A., Miklos Keseru, G., Oliva, G.
10.1101/2022.09.26.509485 — Posted: 2022-09-26
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Ko, E. R., Anstrom, K. J., Panettieri, R. A., Lachiewicz, A. M., Maillo, M., O'Halloran, J., Boucher, C., Smith, P. B., McCarthy, M. W., Segura Nunez, P., Mendivil Tuchia de Tai, S., Khan, A., Mena Lora, A. J., Salathe, M., Kedar, E., Capo, G., Rodriguez Gonzalez, D., Patterson, T. F., Palma, C., Ariza, H., Patelli Lima, M., Blamoun, J., Nannini, E., Sprinz, E., Mykietiuk, A., Wang, J. P., Parra-Rodriguez, L., Der, T., Willsey, K., Benjamin, D. K., Wen, J., Zakroysky, P., Halabi, S., Silverstein, A., McNulty, S. E., O'Brien, S. M., Al-Khalidi, H. R., Butler, S., Atkinson, J., Adam, S. J., Chang, S., Maldonado, M. A., Proscham, M., LaVange, L., Bozzette, S. A., Powderly, W. G.
10.1101/2022.09.22.22280247 — Posted: 2022-09-26
SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3
Schindewolf, C., Lokugamage, K., Vu, M., Johnson, B. A., Scharton, D., Plante, J. A., Kalveram, B. K., Crocquet-Valdes, P. A., Sotcheff, S. L., Jaworski, E., Alvarado, R. E., Debbink, K., Daugherty, M. D., Weaver, S., Routh, A. L., Walker, D. H., Plante, K. S., Menachery, V. D.
10.1101/2022.09.26.509529 — Posted: 2022-09-26
Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against Omicron
Chi, X., Xia, L., Zhang, G., Chi, X., Huang, B., Zhang, Y., Chen, Z., Han, J., Wu, L., Li, Z., Sun, H., Huang, P., Yu, C., Chen, W., Zhou, Q.
10.1101/2022.09.25.509344 — Posted: 2022-09-26
Nanobodies for the treatment of SARS-CoV-2 in animals: a meta-analysis
jiao, j., lin, s. l., liang, z. q., Wu, P.
10.1101/2022.09.26.509459 — Posted: 2022-09-26
Zymosan-induced leukocyte and cytokine changes in pigs: a new model for streamlined drug testing against severe COVID-19
Kokeny, G., Bakos, T., Barta, B. A., Nagy, G. V., Meszaros, T., Kozma, G. T., Szabo, A., Szebeni, J., Merkely, B., Radovits, T.
10.1101/2022.09.23.509252 — Posted: 2022-09-26
Spatial transcriptomic profiling of coronary endothelial cells in SARS-CoV-2 myocarditis
Margaroli, C., Benson, P., Gastanadui, M. G., Song, C., Viera, L., Xing, D., Wells, J. M., Patel, R., Gaggar, A., Payne, G. A.
10.1101/2022.09.25.509426 — Posted: 2022-09-26
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Tan, T. J. C., Mou, Z., Lei, R., Ouyang, W. O., Yuan, M., Song, G., Andrabi, R., Wilson, I. A., Kieffer, C., Dai, X., Matreyek, K. A., Wu, N. C.
10.1101/2022.09.24.509341 — Posted: 2022-09-26
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta
Carter, B., Huang, P., Liu, G., Liang, Y., Lin, P. J. C., Peng, B.-H., McKay, L., Dimitrakakis, A., Hsu, J., Tat, V., Saenkham-Huntsinger, P., Chen, J., Kaseke, C., Gaiha, G. D., Xu, Q., Griffiths, A., Tam, Y. K., Tseng, C.-T. K., Gifford, D. K.
10.1101/2022.09.23.509206 — Posted: 2022-09-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).